MD-18
- Generic Name
- MD-18
Subcutaneously Administered MD-18 for the Treatment of Obesity and Diabetes
- First Posted Date
- 2024-12-18
- Last Posted Date
- 2025-02-14
- Lead Sponsor
- Cohen Global, Ltd.
- Target Recruit Count
- 54
- Registration Number
- NCT06739707
- Locations
- 🇮🇱
Sheba Medical Center, Ramat-gan, Please select, Israel
Subcutaneous Administration of MD-18 in Healthy Subjects
- First Posted Date
- 2024-02-14
- Last Posted Date
- 2024-10-01
- Lead Sponsor
- Cohen Global, Ltd.
- Target Recruit Count
- 35
- Registration Number
- NCT06259903
- Locations
- 🇮🇱
Sheba Medical Center, Ramat-gan, Please select, Israel
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath